ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 698090 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 698090; 2) Community: the network communities that were significantly associated with the response to NSC 698090; 3) Molecule: the relationships between components within communities and NSC 698090; 4) MDR: the compounds that were significantly associated with the NSC 698090.

NSC Compound Enrichment Correlation
NSC 615291 Bizelesin 0.0105244982742819 -0.33062387
NSC 618759 4-Penten-3-one, 5,5'-(1,4-phenylenbis)bis[2,2-dimethyl- 1-piperidino-, (E,E)-, dihydrobromide 0.0105244982742819 0.20628607
NSC 681632 Camptothecin Derivative 0.0105244982742819 -0.19336804
NSC 681641 Camptothecin Derivative 0.0105244982742819 -0.0062432934
NSC 697730 Null 0.0105244982742819 0.34609428
NSC 701666 Benzenamine, N-[4-(4-chlorophenyl)-3-(2-propenyl)- 2(3H)-thiazolylidene]-2-methoxy-, hydrobromide, (2Z)- 0.0105244982742819 0.1454947
NSC 727729 1, 1'[Pentane-1,5-diyl)dioxy]bis(11as)-2-fluoro-7-methoxy-1,2,3 ,11a-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepin-5-one 0.0105244982742821 -0.17111455
NSC 759878 Irinotecan hydrochloride (USAN) 0.0105244982742821 -0.076344286
NSC 83950 A 050165L302 0.0105244982742821 -0.048506042
NSC 218476 .beta.-D-Glucopyranose, 6-thio-, 6-(dimethylarsinite) 0.0105607789694646 0.35898542
Total:53  Current:12    [First] [Prev] [Next] [Last]